GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,553.00p
   
  • Change Today:
      29.50p
  • 52 Week High: 1,812.50p
  • 52 Week Low: 1,345.40p
  • Currency: UK Pounds
  • Shares Issued: 4,145.04m
  • Volume: 5,189,575
  • Market Cap: £64,372m
  • RiskGrade: 129

Largest Deals (365 days)

Show trades greater than:
Traded Action Notifier PriceAmountValue
16-Apr-24 Buy Dividends Hal Barron 3,202.70p 2,906,213 £93,077,316.08
16-Apr-24 Buy Dividends Emma Walmsley 1,611.28p 1,840,922 £29,662,409.10
16-Feb-24 Sell Emma Walmsley 1,657.97p 139,792 £2,317,709.49
24-Aug-23 Sell Hal Barron 3,461.74p 58,157 £2,013,244.20
24-Aug-23 Sell Hal Barron 3,461.74p 19,446 £673,169.98
01-Feb-24 Buy Julie Brown 1,582.80p 19,360 £306,430.08
22-Feb-24 Buy Hal Barron 1,737.62p 5,547 £96,385.75
16-Jul-24 Buy Hal Barron 2,985.56p 2,859 £85,363.23
16-May-24 Buy Dividends Hal Barron 3,542.25p 2,433 £86,183.04
17-Aug-23 Buy Dividends Hal Barron 2,734.98p 2,919 £79,830.71
16-Nov-23 Buy Dividends Hal Barron 1,387.09p 5,606 £77,760.14
16-Jan-24 Buy Dividends Hal Barron 2,002.20p 3,947 £79,026.83
15-Jan-24 Buy Dividends Emma Walmsley 1,556.40p 4,947 £76,999.84
16-Oct-23 Buy Dividends Emma Walmsley 1,519.80p 5,020 £76,297.02
20-Jun-24 Buy Charles Bancroft 3,220.87p 1,811 £58,329.90
20-Mar-24 Buy Charles Bancroft 1,638.72p 3,306 £54,176.05
01-Feb-24 Buy Jonathan Symonds 1,570.62p 3,500 £54,971.70
20-Dec-23 Buy Charles Bancroft 2,897.38p 1,757 £50,906.88
20-Sep-23 Buy Charles Bancroft 1,540.17p 3,382 £52,088.46
20-Mar-24 Buy Jonathan Symonds 1,659.89p 2,900 £48,136.81

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,553.00p
Change Today 29.50p
% Change 1.94 %
52 Week High 1,812.50p
52 Week Low 1,345.40p
Volume 5,189,575
Shares Issued 4,145.04m
Market Cap £64,372m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
40.28% below the market average40.28% below the market average40.28% below the market average40.28% below the market average40.28% below the market average
80.39% above the sector average80.39% above the sector average80.39% above the sector average80.39% above the sector average80.39% above the sector average
Price Trend
8.93% above the market average8.93% above the market average8.93% above the market average8.93% above the market average8.93% above the market average
57.69% above the sector average57.69% above the sector average57.69% above the sector average57.69% above the sector average57.69% above the sector average
Income
37.68% above the market average37.68% above the market average37.68% above the market average37.68% above the market average37.68% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
12.69% below the market average12.69% below the market average12.69% below the market average12.69% below the market average12.69% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average

What The Brokers Say

Strong Buy 8
Buy 4
Neutral 10
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 16-May-24 22-Feb-24
Paid 11-Jul-24 11-Apr-24
Amount 15.00p 16.00p

Trades for 26-Jul-2024

Time Volume / Share Price
18:55 100,321 @ 1,669.26p
16:49 8 @ 1,553.00p
16:39 2,580 @ 1,553.00p
16:39 5,160 @ 1,553.00p
16:39 7,740 @ 1,553.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page